A1 Refereed original research article in a scientific journal
The prototype endothelial marker PAL-E is a leukocyte trafficking molecule.
Authors: Keuschnigg J, Henttinen T, Auvinen K, Karikoski M, Salmi M, Jalkanen S
Publisher: AMER SOC HEMATOLOGY
Publishing place: Washington DC
Publication year: 2009
Journal: Blood
Journal name in source: Blood
Journal acronym: Blood
Volume: 114
Issue: 2
First page : 478
Last page: 84
Number of pages: 7
ISSN: 1528-0020
DOI: https://doi.org/10.1182/blood-2008-11-188763
Pathologische Anatomie Leiden-endothelium antibody has been used for more than 20 years as a marker for vascular endothelium. Despite its widespread use, the target of this antibody was only recently identified as plasmalemma vesicle-associated protein-1 (PV-1). However, no function has been identified for this molecule. Here we report that activation of human umbilical vein endothelial cells with tumor necrosis factor-alpha resulted in a remarkable redistribution of PV-1 toward the peripheral areas of the cells. Furthermore, in vitro endpoint transmigration experiments showed that transcellularly migrating lymphocytes are surrounded by rings containing PV-1 and caveolin-1. Moreover, PV-1 associates physically with vimentin. In addition, administration of anti-PV-1 antibody during capillary flow assays resulted in a significant inhibition of lymphocyte transmigration through the endothelial cell layer, whereas rolling and adhesion were unaffected. In vivo blockage of PV-1 by an antibody in acute peritonitis and air pouch model resulted in a significant decrease in the number of migrating leukocytes. Here we thus define leukocyte transendothelial migration as the first known function for PV-1.